Private Wealth Asset Management, LLC
Position in PBYI — Puma Biotechnology, Inc.
CIK 1883006
OMAHA, NE
Position in PBYI
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$28,385
+$6,020 QoQ
Shares Held
3,500
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#114
of 161 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Private Wealth Asset Management, LLC holds $425,965 across 17 Biotechnology names. PBYI ranks #4 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
401 | $199,188 | |
| 2 | RPRX |
Royalty Pharma plc
|
906 | $50,799 | |
| 3 | INSM |
INSMED Inc
|
333 | $35,504 | |
| 4 | PBYI |
Puma Biotechnology, Inc.
This page
|
3,500 | $28,385 | |
| 5 | QTTB |
Q32 Bio Inc.
|
1,700 | $21,658 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
31 | $19,329 | |
| 7 | RIGL |
Rigel Pharmaceuticals Inc
|
400 | $15,648 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
41 | $12,342 |
All Filings in PBYI
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,385 | 3,500 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $22,365 | 3,500 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $20,825 | 3,500 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $18,585 | 3,500 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $12,005 | 3,500 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $5,920 | 2,000 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||